Literature DB >> 15276647

Increased gut-derived norepinephrine release in sepsis: up-regulation of intestinal tyrosine hydroxylase.

Mian Zhou1, H Hank Simms, Ping Wang.   

Abstract

Studies have shown that increased gut-derived norepinephrine (NE) release plays an important role in producing hepatocellular dysfunction at the early stage of sepsis. Although the gut has been demonstrated to be the major source of NE in sepsis, it remains unknown whether the increased NE is associated with up-regulation of intestinal NE biosynthesis enzymes such as tyrosine hydroxylase (TH) and dopamine beta-hydroxylase (DBH). To determine this, adult male rats were subjected to sepsis by cecal ligation and puncture (CLP) followed by fluid resuscitation. Small intestinal samples were harvested at 2 h (i.e., early sepsis) or 20 h (late sepsis) after CLP or sham-operation. Protein levels of TH and DBH were determined by Western blot analysis and immunohistochemistry. Their gene expression was assessed by RT-PCR technique. The results indicate that intestinal TH protein levels increased significantly at 2 and 20 h after CLP, while DBH was not altered under such conditions. Immunohistochemical examination shows that both TH and DBH were located in intestinal sympathetic nerve fibers and TH staining was markedly increased in septic animals. TH gene expression increased significantly at 2 h but not at 20 h after CLP, while DBH gene expression was not altered in sepsis. Thus, the increased TH gene and protein expression appears to be responsible for the increased gut-derived NE in sepsis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276647     DOI: 10.1016/j.bbadis.2004.03.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

2.  Norepinephrine released by intestinal Paneth cells exacerbates ischemic AKI.

Authors:  Sang Jun Han; Mihwa Kim; Vivette Denise D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-09

Review 3.  Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box?

Authors:  Michael A Flierl; Daniel Rittirsch; Markus Huber-Lang; J Vidya Sarma; Peter A Ward
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

4.  Chronic low-level lead exposure affects the monoaminergic system in the mouse superior olivary complex.

Authors:  Tyler Fortune; Diana I Lurie
Journal:  J Comp Neurol       Date:  2009-04-10       Impact factor: 3.215

5.  Renalase protects against ischemic AKI.

Authors:  H Thomas Lee; Joo Yun Kim; Mihwa Kim; Peili Wang; Lieqi Tang; Sara Baroni; Vivette D D'Agati; Gary V Desir
Journal:  J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 10.121

6.  Upregulation of myocardial syntaxin1A is associated with an early stage of polymicrobial sepsis.

Authors:  Padmalaya Das; Mani Chopra; Avadhesh C Sharma
Journal:  Mol Cell Biochem       Date:  2008-11-28       Impact factor: 3.396

7.  Evidence for a regional specificity in the density and distribution of noradrenergic varicosities in rat cortex.

Authors:  Kara L Agster; Carlos A Mejias-Aponte; Brian D Clark; Barry D Waterhouse
Journal:  J Comp Neurol       Date:  2013-07-01       Impact factor: 3.215

8.  Norepinephrine increases the pathogenic potential of Campylobacter jejuni.

Authors:  T A Cogan; A O Thomas; L E N Rees; A H Taylor; M A Jepson; P H Williams; J Ketley; T J Humphrey
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

Review 9.  Communication between Bacteria and Their Hosts.

Authors:  Primrose Freestone
Journal:  Scientifica (Cairo)       Date:  2013-12-08

Review 10.  The sympathetic nervous response in inflammation.

Authors:  Georg Pongratz; Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.